Clemens H’s study found that platelets from non-small-cell lung cancer (NSCLC) patients expressed PD-L1, and PD-L1 could transfer from tumor cells to platelets in an integrin- and GPIbα-dependent manner in tumor immune evasion (Hinterleitner et al., 2021). Here, GP1BA is linked to neoplasm.